{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:01:24Z","timestamp":1791669684821,"version":"4.3.4"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/shk.0b013e31815dd92f","type":"journal-article","created":{"date-parts":[[2008,5,13]],"date-time":"2008-05-13T03:07:11Z","timestamp":1210648031000},"page":"656-661","source":"Crossref","is-referenced-by-count":109,"title":["CIRCULATING ANGIOPOIETIN 2 CORRELATES WITH MORTALITY IN A SURGICAL POPULATION WITH ACUTE LUNG INJURY\/ADULT RESPIRATORY DISTRESS SYNDROME"],"prefix":"10.1097","volume":"29","author":[{"given":"Diana C.","family":"Gallagher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir M.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Balonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Talmor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas P.","family":"Sukhatme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"7","key":"R1-2-20210213","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.","author":"Suri","year":"1996","journal-title":"Cell"},{"key":"R2-2-20210213","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.RES.87.7.603","article-title":"Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions.","volume":"87","author":"Gamble","year":"2000","journal-title":"Circ Res"},{"key":"R3-2-20210213","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1126\/science.286.5449.2511","article-title":"Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.","volume":"286","author":"Thurston","year":"1999","journal-title":"Science"},{"key":"R4-2-20210213","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/hh1801.097034","article-title":"Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression.","volume":"89","author":"Kim","year":"2001","journal-title":"Circ Res"},{"key":"R5-2-20210213","doi-asserted-by":"crossref","first-page":"15491","DOI":"10.1073\/pnas.0607538103","article-title":": Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells.","volume":"103","author":"Daly","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-2-20210213","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1371\/journal.pmed.0030046","article-title":"Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans.","volume":"3","author":"Parikh","year":"2006","journal-title":"PLoS Med"},{"key":"R7-2-20210213","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.105.086553","article-title":"Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage.","volume":"314","author":"Roviezzo","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R8-2-20210213","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/74725","article-title":"Angiopoietin-1 protects the adult vasculature against plasma leakage.","volume":"6","author":"Thurston","year":"2000","journal-title":"Nat Med"},{"key":"R9-2-20210213","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.CIR.0000151287.08202.8E","article-title":"Protective role of angiopoietin-1 in endotoxic shock.","volume":"111","author":"Witzenbichler","year":"2005","journal-title":"Circulation"},{"key":"R10-2-20210213","doi-asserted-by":"crossref","first-page":"H107","DOI":"10.1152\/ajpheart.00542.2005","article-title":"Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules.","volume":"290","author":"Baffert","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R11-2-20210213","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/shk.0b013e318123867b","article-title":"Admission angiopoietin levels in children with septic shock.","volume":"28","author":"Giuliano","year":"2007","journal-title":"Shock"},{"key":"R12-2-20210213","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/nm1494","article-title":": Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death.","volume":"12","author":"Bhandari","year":"2006","journal-title":"Nat Med"},{"key":"R13-2-20210213","first-page":"985","article-title":"Regulation of endothelin-1 by angiopoietin-1: implications for inflammation.","volume":"231","author":"McCarter","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"R14-2-20210213","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1164\/rccm.200609-1370OC","article-title":": Cell-based angiopoietin-1 gene therapy for acute lung injury.","volume":"175","author":"McCarter","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-2-20210213","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.","volume":"149","author":"Bernard","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-2-20210213","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1164\/ajrccm\/138.3.720","article-title":"An expanded definition of the adult respiratory distress syndrome.","volume":"138","author":"Murray","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"R17-2-20210213","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF01708091","article-title":"The acute respiratory distress syndrome: definitions, severity and clinical outcome. An analysis of 101 clinical investigations.","volume":"22","author":"Krafft","year":"1996","journal-title":"Intensive Care Med"},{"key":"R18-2-20210213","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1378\/chest.101.4.1074","article-title":"The adult respiratory distress syndrome. A report of survival and modifying factors.","volume":"101","author":"Suchyta","year":"1992","journal-title":"Chest"},{"key":"R19-2-20210213","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s001340000683","article-title":"Acute respiratory distress syndrome in trauma patients: ICU mortality and prediction factors.","volume":"26","author":"Navarrete-Navarro","year":"2000","journal-title":"Intensive Care Med"},{"key":"R20-2-20210213","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1017\/S0265021505001870","article-title":"Predictors of mortality in ARDS patients referred to a tertiary care centre: a pilot study.","volume":"23","author":"Luecke","year":"2006","journal-title":"Eur J Anaesthesiol"},{"key":"R21-2-20210213","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1158\/1078-0432.CCR-06-2509","article-title":"Angiopoietin 2 is a potential mediator of high-dose interleukin 2-induced vascular leak.","volume":"13","author":"Gallagher","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R22-2-20210213","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1097\/01.CCM.0000155788.39101.7E","article-title":"Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design.","volume":"33","author":"Ware","year":"2005","journal-title":"Crit Care Med"},{"key":"R23-2-20210213","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1378\/chest.108.5.1303","article-title":"Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome.","volume":"108","author":"Meduri","year":"1995","journal-title":"Chest"},{"key":"R24-2-20210213","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1378\/chest.107.4.1062","article-title":"Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time.","volume":"107","author":"Meduri","year":"1995","journal-title":"Chest"},{"key":"R25-2-20210213","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1097\/00003246-200112000-00016","article-title":"von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury.","volume":"29","author":"Ware","year":"2001","journal-title":"Crit Care Med"},{"key":"R26-2-20210213","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1097\/01.CCM.0000126121.56990.D3","article-title":"Plasma protein C levels in patients with acute lung injury: prognostic significance.","volume":"32","author":"Matthay","year":"2004","journal-title":"Crit Care Med"},{"key":"R27-2-20210213","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/thorax.58.11.983","article-title":"Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury.","volume":"58","author":"Eisner","year":"2003","journal-title":"Thorax"},{"key":"R28-2-20210213","doi-asserted-by":"crossref","first-page":"L426","DOI":"10.1152\/ajplung.00302.2004","article-title":"Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury.","volume":"288","author":"Parsons","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R29-2-20210213","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s001340100955","article-title":"Acute respiratory distress syndrome among trauma patients: trends in ICU mortality, risk factors, complications and resource utilization.","volume":"27","author":"Navarrete-Navarro","year":"2001","journal-title":"Intensive Care Med"},{"key":"R30-2-20210213","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/path.1491","article-title":"Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome.","volume":"202","author":"Bhatia","year":"2004","journal-title":"J Pathol"},{"key":"R31-2-20210213","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/cc5037","article-title":"Biological markers of lung injury before and after the institution of positive pressure ventilation in patients with acute lung injury.","volume":"10","author":"Cepkova","year":"2006","journal-title":"Crit Care"},{"key":"R32-2-20210213","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.it.2006.10.004","article-title":"Angiopoietins: a link between angiogenesis and inflammation.","volume":"27","author":"Fiedler","year":"2007","journal-title":"Trends Immunol"},{"key":"R33-2-20210213","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm1351","article-title":"U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N et al.: Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation.","volume":"12","year":"2006","journal-title":"Nat Med"},{"key":"R34-2-20210213","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.CCM.0000251640.77679.D7","article-title":": Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators.","volume":"35","author":"Orfanos","year":"2007","journal-title":"Crit Care Med"},{"key":"R35-2-20210213","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/713773924","article-title":"Endothelial gaps as sites for plasma leakage in inflammation.","volume":"6","author":"McDonald","year":"1999","journal-title":"Microcirculation"},{"key":"R36-2-20210213","first-page":"L61","article-title":"Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli.","volume":"266","author":"McDonald","year":"1994","journal-title":"Am J Physiol"},{"key":"R37-2-20210213","doi-asserted-by":"crossref","first-page":"L289","DOI":"10.1152\/ajplung.00343.2005","article-title":"Endothelial cell barrier enhancement by ATP is mediated by the small GTPase Rac and cortactin.","volume":"291","author":"Jacobson","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R38-2-20210213","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1096\/fj.01-0556fje","article-title":"Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells.","volume":"16","author":"Kim","year":"2002","journal-title":"FASEB J"},{"key":"R39-2-20210213","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.bjp.0705259","article-title":"Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production.","volume":"139","author":"Pizurki","year":"2003","journal-title":"Br J Pharmacol"},{"key":"R41-2-20210213","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/01.RES.0000218275.54089.12","article-title":"Signaling and functions of angiopoietin-1 in vascular protection.","volume":"98","author":"Brindle","year":"2006","journal-title":"Circ Res"},{"key":"R42-2-20210213","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1067\/mtc.2001.113753","article-title":"Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy.","volume":"122","author":"Thistlethwaite","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R43-2-20210213","doi-asserted-by":"crossref","first-page":"12331","DOI":"10.1073\/pnas.1933740100","article-title":"Induction of pulmonary hypertension by an angiopoietin 1\/TIE2\/serotonin pathway.","volume":"100","author":"Sullivan","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R44-2-20210213","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ccr.2004.09.030","article-title":": Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2.","volume":"6","author":"Oliner","year":"2004","journal-title":"Cancer Cell"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00024382-200806000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:03:48Z","timestamp":1786035828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00024382-200806000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/shk.0b013e31815dd92f","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}